A Randomized Controlled Trial of Extended Intermittent Preventive Antimalarial Treatment in Infants | Zendy

Robin Kobbe | Zendy; Christina Kreuzberg | Zendy; Samuel Adjei | Zendy; Bruce Thompson | Zendy; Iris Langefeld | Zendy; Paul A. Thompson | Zendy; H. H. Abruquah | Zendy; Benno Kreuels | Zendy; Matilda Ayim | Zendy; Wibke Busch | Zendy; Florian Marks | Zendy; Kwesi Amoah | Zendy; Ernest Opoku | Zendy; Christian G. Meyer | Zendy; Ohene Adjei | Zendy; Jürgen May | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Randomized Controlled Trial of Extended Intermittent Preventive Antimalarial Treatment in Infants

Author(s) -

Robin Kobbe,

Christina Kreuzberg,

Samuel Adjei,

Bruce Thompson,

Iris Langefeld,

Paul A. Thompson,

H. H. Abruquah,

Benno Kreuels,

Matilda Ayim,

Wibke Busch,

Florian Marks,

Kwesi Amoah,

Ernest Opoku,

Christian G. Meyer,

Ohene Adjei,

Jürgen May

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/518575

Subject(s) - medicine , malaria , sulfadoxine , pyrimethamine , plasmodium falciparum , sulfadoxine/pyrimethamine , randomized controlled trial , pediatrics , anemia , intensive care medicine , immunology , surgery

Intermittent preventive antimalarial treatment in infants (IPTi) with sulfadoxine-pyrimethamine reduces falciparum malaria and anemia but has not been evaluated in areas with intense perennial malaria transmission. It is unknown whether an additional treatment in the second year of life prolongs protection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research